ArticleJournal for immunotherapy of cancer2023

Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity.

Laura Fernandez-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.